MidWestOne Financial Group’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.68M | Buy |
34,712
+14,195
| +69% | +$1.51M | 0.48% | 47 |
|
|
2025
Q1 | $2.55M | Sell |
20,517
-3,830
| -16% | -$475K | 0.36% | 63 |
|
|
2024
Q4 | $3M | Buy |
24,347
+2,284
| +10% | +$281K | 0.42% | 50 |
|
|
2024
Q3 | $2.46M | Buy |
22,063
+1,134
| +5% | +$126K | 0.34% | 63 |
|
|
2024
Q2 | $2.23M | Buy |
20,929
+8,083
| +63% | +$863K | 0.4% | 61 |
|
|
2024
Q1 | $1.55M | Buy |
12,846
+4,084
| +47% | +$492K | 0.28% | 101 |
|
|
2023
Q4 | $1.08M | Buy |
8,762
+205
| +2% | +$25.2K | 0.2% | 120 |
|
|
2023
Q3 | $1.11M | Sell |
8,557
-3,081
| -26% | -$399K | 0.25% | 108 |
|
|
2023
Q2 | $1.44M | Buy |
11,638
+1,944
| +20% | +$241K | 0.31% | 81 |
|
|
2023
Q1 | $1.42M | Buy |
9,694
+1,833
| +23% | +$268K | 0.32% | 73 |
|
|
2022
Q4 | $2.67M | Buy |
7,861
+202
| +3% | +$68.7K | 0.6% | 23 |
|
|
2022
Q3 | $1.02M | Sell |
7,659
-275
| -3% | -$36.7K | 0.26% | 92 |
|
|
2022
Q2 | $1.24M | Sell |
7,934
-172
| -2% | -$26.8K | 0.31% | 78 |
|
|
2022
Q1 | $1.26M | Sell |
8,106
-2,827
| -26% | -$440K | 0.27% | 88 |
|
|
2021
Q4 | $1.39M | Buy |
10,933
+3,898
| +55% | +$497K | 0.29% | 84 |
|
|
2021
Q3 | $916K | Buy |
+7,035
| New | +$916K | 0.21% | 114 |
|
|
2020
Q2 | – | Sell |
-5,461
| Closed | -$545K | – | 155 |
|
|
2020
Q1 | $545K | Buy |
5,461
+2,077
| +61% | +$207K | 0.2% | 114 |
|
|
2019
Q4 | $505K | Buy |
+3,384
| New | +$505K | 0.1% | 148 |
|